585 related articles for article (PubMed ID: 24121580)
1. [Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis: advances in pathogenesis and treatment].
Silva F; Cisternas M
Rev Med Chil; 2013 Jun; 141(6):765-73. PubMed ID: 24121580
[TBL] [Abstract][Full Text] [Related]
2. ANCA associated vasculitis (AAV): a review for internists.
Yaseen K; Mandell BF
Postgrad Med; 2023 Jan; 135(sup1):3-13. PubMed ID: 35831990
[TBL] [Abstract][Full Text] [Related]
3. Current therapies for ANCA-associated vasculitis.
Lally L; Spiera R
Annu Rev Med; 2015; 66():227-40. PubMed ID: 25341007
[TBL] [Abstract][Full Text] [Related]
4. ANCA-associated vasculitis.
Yates M; Watts R
Clin Med (Lond); 2017 Feb; 17(1):60-64. PubMed ID: 28148583
[TBL] [Abstract][Full Text] [Related]
5. The role of rituximab in the treatment of ANCA-associated vasculitides (AAV).
Daikeler T; Kistler AD; Martin PY; Vogt B; Huynh-Do U
Swiss Med Wkly; 2015; 145():w14103. PubMed ID: 25658140
[TBL] [Abstract][Full Text] [Related]
6. New advances in the pathogenesis of ANCA-associated vasculitides.
Chen M; Kallenberg CG
Clin Exp Rheumatol; 2009; 27(1 Suppl 52):S108-14. PubMed ID: 19646356
[TBL] [Abstract][Full Text] [Related]
7. Paediatric anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis: an update on renal management.
Plumb LA; Oni L; Marks SD; Tullus K
Pediatr Nephrol; 2018 Jan; 33(1):25-39. PubMed ID: 28062909
[TBL] [Abstract][Full Text] [Related]
8. Pathogenesis of ANCA-associated vasculitis: new possibilities for intervention.
Kallenberg CG; Stegeman CA; Abdulahad WH; Heeringa P
Am J Kidney Dis; 2013 Dec; 62(6):1176-87. PubMed ID: 23810690
[TBL] [Abstract][Full Text] [Related]
9. ANCA-Associated Vasculitis: Core Curriculum 2020.
Geetha D; Jefferson JA
Am J Kidney Dis; 2020 Jan; 75(1):124-137. PubMed ID: 31358311
[TBL] [Abstract][Full Text] [Related]
10. Antineutrophil cytoplasmic antibody-associated vasculitides: is it time to split up the group?
Millet A; Pederzoli-Ribeil M; Guillevin L; Witko-Sarsat V; Mouthon L
Ann Rheum Dis; 2013 Aug; 72(8):1273-9. PubMed ID: 23606701
[TBL] [Abstract][Full Text] [Related]
11. Treatment of antineutrophil cytoplasmic antibody-associated vasculitis with rituximab.
Cartin-Ceba R; Fervenza FC; Specks U
Curr Opin Rheumatol; 2012 Jan; 24(1):15-23. PubMed ID: 22089095
[TBL] [Abstract][Full Text] [Related]
12. Rituximab in ANCA-associated vasculitis: fad or fact?
Fervenza FC
Nephron Clin Pract; 2011; 118(2):c182-8; discussion c188. PubMed ID: 21160229
[TBL] [Abstract][Full Text] [Related]
13. Targeted immunotherapy strategies in ANCA-associated vasculitis.
Puéchal X
Joint Bone Spine; 2019 May; 86(3):321-326. PubMed ID: 30201478
[TBL] [Abstract][Full Text] [Related]
14. Republished: Antineutrophil cytoplasmic antibody-associated vasculitides: is it time to split up the group?
Millet A; Pederzoli-Ribeil M; Guillevin L; Witko-Sarsat V; Mouthon L
Postgrad Med J; 2014 May; 90(1063):290-6. PubMed ID: 24737903
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory bowel diseases in anti-neutrophil cytoplasmic antibody-associated vasculitides: 11 retrospective cases from the French Vasculitis Study Group.
Humbert S; Guilpain P; Puéchal X; Terrier B; Rivière S; Mahr A; Pagnoux C; Bagnères D; Cordier JF; Le Quellec A; Altwegg R; Guillevin L;
Rheumatology (Oxford); 2015 Nov; 54(11):1970-5. PubMed ID: 26106214
[TBL] [Abstract][Full Text] [Related]
16. An update on dıagnosıs and treatment of ANCA assocıated renal vasculıtıs.
Turkmen K; Ozer H; Tesar V
Int Urol Nephrol; 2023 Nov; 55(11):2817-2827. PubMed ID: 37010734
[TBL] [Abstract][Full Text] [Related]
17. Childhood GPA, EGPA, and MPA.
Jariwala M; Laxer RM
Clin Immunol; 2020 Feb; 211():108325. PubMed ID: 31837445
[TBL] [Abstract][Full Text] [Related]
18. Pathophysiology of ANCA-associated vasculitis.
Lenka B; Zdenka H; Eva H
Cesk Patol; 2020; 56(2):65-67. PubMed ID: 32493021
[TBL] [Abstract][Full Text] [Related]
19. Novel Therapies for ANCA-associated Vasculitis.
Monti S; Brandolino F; Milanesi A; Xoxi B; Delvino P; Montecucco C
Curr Rheumatol Rep; 2021 Apr; 23(6):38. PubMed ID: 33909172
[TBL] [Abstract][Full Text] [Related]
20. Environmental factors influencing the risk of ANCA-associated vasculitis.
Zhao WM; Wang ZJ; Shi R; Zhu YY; Zhang S; Wang RF; Wang DG
Front Immunol; 2022; 13():991256. PubMed ID: 36119110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
